276 results
Page 2 of 14
8-K
EX-2.1
5tvlxf3k
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.2
3x6hwreew3fl d8t
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.1
lyss hrv932h
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
jk3wi
23 Mar 22
Business combination disclosure
5:29pm
425
uqh6q
23 Mar 22
Business combination disclosure
5:29pm
8-K
fbkq wmp9ei
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
1fa39ijgf70dxzn2wov
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
fg94qys6
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.1
e7c24hef
17 Feb 22
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm
8-K
EX-99.1
8vzgvw
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K/A
EX-99.1
810ynkljqn937aeel
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-99.1
q3uf8 idbmv2q01d
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
m8u 14jn5
13 Oct 20
Entry into a Material Definitive Agreement
8:44am